Cogent Biosciences
COGT
#6495
Rank
$0.54 B
Marketcap
$4.77
Share price
-10.51%
Change (1 day)
-30.87%
Change (1 year)

Cogent Biosciences (COGT) - Cash on Hand

Cash on Hand as of December 2024 : $0.28 Billion USD

According to Cogent Biosciences's latest financial reports the company has $0.28 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cogent Biosciences - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.28 B8.04%
2023-12-31$0.26 B2.48%
2022-12-31$0.25 B18.02%
2021-12-31$0.21 B-9.29%
2020-12-31$0.24 B547.15%
2019-12-31$37.42 M-52.38%
2018-12-31$78.59 M91.88%
2017-12-31$40.96 M-40.21%
2016-12-31$68.5 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$16.39 M-94.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.43 B 50.46%๐Ÿ‡บ๐Ÿ‡ธ USA